| Filed On | Filing |
|---|---|
| 25 Jan 2024 |
8-K/A: Financial Statements and Exhibits
See the accompanying Index to Exhibits, which information is hereby incorporated herein by reference. |
| 18 Aug 2023 |
8-K/A: Entry into a Material Definitive Agreement; Submission of Matters to a Vote of Security Holders
The Notes will be the senior subordinate obligations of the Company and not the financial obligations of our subsidiaries. The principal amount of the Notes accrue interest at a rate of 8% per annum (the “Interest Rate”), which will adju... |
| 12 Apr 2023 |
8-K/A: Entry into a Material Definitive Agreement
On April 5, 2023, Evofem Biosciences, Inc., a Delaware corporation (the “Company”) entered into a securities purchase agreement (“SPA”), with certain investors (the “Investors”) providing for the sale and issuance of senior subordinate c... |
| 16 Feb 2022 | 8-K/A: Entry into a Material Definitive Agreement |
| 12 Aug 2021 | 8-K/A: Results of Operations and Financial Condition |
| 06 Apr 2018 | 8-K/A: Financial Statements and Exhibits |
| 05 Mar 2018 | 8-K/A: Other Events |
| 01 Mar 2018 | 8-K/A: Financial Statements and Exhibits |
| 31 Oct 2017 | 8-K/A: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +2 more |
| 12 Jul 2017 | 8-K/A: Costs Associated with Exit or Disposal Activities; Departure/Election of Directors or Officers; Compensation +1 more |
| 29 Sep 2015 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
Loading...
